CombiMatrix to provide tests for American Pathology Partners

|About: CombiMatrix Corporation (CBMX)|By:, SA News Editor

CombiMatrix (CBMX) will provide its tests for analyzing miscarriages to American Pathology Partners (AP2), which is creating a nationwide network of anatomic pathology laboratories.

The partnership for the chromosomal microarray analysis (CMA) tests is effective immediately and is starting with UniPath, AP2's flagship laboratory in Denver.

CombiMatrix's shares are +5.25%. (PR)